Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,292 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial.
Magrini SM, Buglione M, Corvò R, Pirtoli L, Paiar F, Ponticelli P, Petrucci A, Bacigalupo A, Crociani M, Lastrucci L, Vecchio S, Bonomo P, Pasinetti N, Triggiani L, Cavagnini R, Costa L, Tonoli S, Maddalo M, Grisanti S. Magrini SM, et al. Among authors: costa l. J Clin Oncol. 2016 Feb 10;34(5):427-35. doi: 10.1200/JCO.2015.63.1671. Epub 2015 Dec 7. J Clin Oncol. 2016. PMID: 26644536 Clinical Trial.
Circulating tumour cells in locally advanced head and neck cancer: preliminary report about their possible role in predicting response to non-surgical treatment and survival.
Buglione M, Grisanti S, Almici C, Mangoni M, Polli C, Consoli F, Verardi R, Costa L, Paiar F, Pasinetti N, Bolzoni A, Marini M, Simoncini E, Nicolai P, Biti G, Magrini SM. Buglione M, et al. Among authors: costa l. Eur J Cancer. 2012 Nov;48(16):3019-26. doi: 10.1016/j.ejca.2012.05.007. Epub 2012 Jun 7. Eur J Cancer. 2012. PMID: 22682019
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer.
Buglione M, Maddalo M, Corvò R, Pirtoli L, Paiar F, Lastrucci L, Stefanacci M, Belgioia L, Crociani M, Vecchio S, Bonomo P, Bertocci S, Borghetti P, Pasinetti N, Triggiani L, Costa L, Tonoli S, Grisanti S, Magrini SM. Buglione M, et al. Among authors: costa l. Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):462-472. doi: 10.1016/j.ijrobp.2016.10.011. Epub 2016 Oct 20. Int J Radiat Oncol Biol Phys. 2017. PMID: 27986347 Clinical Trial.
Cetuximab and Radiation Therapy Versus Cisplatin and Radiation Therapy for Locally Advanced Head and Neck Cancer: Long-Term Survival and Toxicity Outcomes of a Randomized Phase 2 Trial.
Maddalo M, Borghetti P, Tomasini D, Corvò R, Bonomo P, Petrucci A, Paiar F, Lastrucci L, Bonù ML, Greco D, Costa L, Pegurri L, Triggiani L, Belgioia L, Desideri I, Grisanti S, Buglione M, Magrini SM. Maddalo M, et al. Among authors: costa l. Int J Radiat Oncol Biol Phys. 2020 Jul 1;107(3):469-477. doi: 10.1016/j.ijrobp.2020.02.637. Epub 2020 Mar 14. Int J Radiat Oncol Biol Phys. 2020. PMID: 32184121 Clinical Trial.
The impact of tumour histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients.
Buglione M, Bandera L, Grisanti S, Pasinetti N, Borghetti P, Barbera F, Triggiani L, Costa L, Shehi B, Bonetti B, Magrini S. Buglione M, et al. Among authors: costa l. Radiol Med. 2012 Feb;117(1):133-47. doi: 10.1007/s11547-011-0738-x. Epub 2011 Oct 21. Radiol Med. 2012. PMID: 22020431 English, Italian.
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part I: Evolving technical choices and survival.
Tonoli S, Magrini SM, Costa L, Paiar F, Simontacchi G, Scotti V, Pasinetti N, Barca R, Barbieri D, De Stefani A, Cellai E, Buglione M, Biti G. Tonoli S, et al. Among authors: costa l. Radiol Med. 2012 Jun;117(4):690-714. doi: 10.1007/s11547-011-0755-9. Epub 2011 Nov 17. Radiol Med. 2012. PMID: 22095424
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part II: Evolving technical choices and toxicity patterns.
Magrini SM, Tonoli S, Costa L, Pasinetti N, Paiar F, Livi L, Simontacchi G, Meattini I, Pegurri L, Borghetti P, Frata P, Ponticelli P, Buglione M, Biti G. Magrini SM, et al. Among authors: costa l. Radiol Med. 2012 Jun;117(4):715-24. doi: 10.1007/s11547-011-0756-8. Epub 2011 Nov 17. Radiol Med. 2012. PMID: 22095425
Salvage Low Dose Rate Brachytherapy For Recurrent Prostate Cancer After External Beam Radiotherapy: Results From A Single Institution With Focus On Toxicity And Functional Outcomes.
Barbera F, Triggiani L, Buglione M, Ghirardelli P, Vitali P, Caraffini B, Borghetti P, Greco D, Bardoscia L, Pasinetti N, Costa L, Maddalo M, Ghedi B, La Face B, Magrini SM. Barbera F, et al. Among authors: costa l. Clin Med Insights Oncol. 2017 Nov 7;11:1179554917738765. doi: 10.1177/1179554917738765. eCollection 2017. Clin Med Insights Oncol. 2017. PMID: 29151782 Free PMC article.
4,292 results